Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-29 to 2025-01-30
Current total value of award: $454.68
Description: 4567097978!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML